alexa Abstract | Effects Of Chronic Treatment With Nitrendipine In Streptozotocin-Induced Diabetic Rats

Indian Journal of Pharmaceutical Sciences
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Paper Open Access


The present investigation involves the study of the effects chronic treatment with oral nitrendipine (15mg/kg/day) in streptozotocin (STZ) induced diabetic rats. Single tail vein injection of STZ (45 mg/kg) produced a diabetic state exhibiting all the cardinal symptoms such as loss of body weight, polyuria, polydipsia, glucosuria, hypoinsulinemia, and hyperglycemia. The diabetic state was also found to be associated with hypothyroidism hypercholesterolemia, bradycardia, hypertension, cardiac depression and cardiomyopathy. Nitrendipine treatment prevented the hypercholesterolemia, hypertension and bradycardia observed in untreated STZ-diabetic rats. It could not prevent however, loss of body weight, hyperglycemia, hypoinsulinemia and hypothyroidism. The cardiac depression and cardiomyopathy were found to be partially prevented by nitrendipine. These data suggests that nitrendipine has certain beneficial effects in diabetic rats.

To read the full article Peer-reviewed Article PDF image

Author(s): S S Joshi T S Shah R K Goyal

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version